Table 6 Multivariate analysis of prognostic factors for 5-year nadir +2 biochemical outcome in a Cox Regression model.
From: Image guided dose escalated prostate radiotherapy: still room to improve
Risk Factor | Number | Nadir +2 5-year bNED | p-value | HR (95%CI) |
|---|---|---|---|---|
PSA | Â | Â | Â | Â |
   <10 | 108 | 72.3% |  | 1 (reference) |
   10-20 | 55 | 86.3% |  |  |
Continuous variable | Â | Â | 0.62 | 0.98 (0.91-1.06) |
Gleason grade | Â | Â | Â | Â |
   5-6 | 31 | 83.4% |  |  |
   7 | 132 | 75.7% | 0.94 | 0.94 (0.47-2.03) |
T-category | Â | Â | Â | Â |
   T1b-T2a | 128 | 79.5% | 0.04 | 1 (reference) |
   T2b-T2c | 35 | 64.3% |  | 1.93 (1.01-3.69) |
Adjuvant Hormone | Â | Â | Â | Â |
   No | 145 | 77.5% |  | 1 (reference) |
   Yes | 18 | 69.3% | 0.41 | 1.44 (0.61-3.42) |
Age | Â | Â | Â | Â |
Continuous variable | Â | Â | 0.57 | 1.02 (0.96-1.07) |